Psychiatry and Neurology, Neurology · Milwaukee, WI
NPI
1780768531
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
9200 W Wisconsin Ave, Dept of Neurology
Milwaukee, WI, 53226
Phone (414) 805-5254
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
494 services
Medicare patients, 2024
112
Average age 66
Drug cost, 2024
$1.4M
652 prescriptions
Company payments, 2025
$1,019
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jennifer M Connelly was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 142 times for 59 patients. In total Jennifer M Connelly billed 494 services in 11 codes, and Medicare paid $27K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-01.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 142 | 59 | $12.15 | $1,725 |
| 99214 Office E&M - Established | Facility | 98 | 62 | $67.53 | $6,618 |
| 99215 Office E&M - Established | Facility | 86 | 38 | $104.01 | $8,945 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 53 | 18 | $12.62 | $669 |
| 99215 Office E&M - Established | Office | 36 | 17 | $103.45 | $3,724 |
| 99214 Office E&M - Established | Office | 28 | 15 | $73.09 | $2,047 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 19 | 11 | $21.15 | $402 |
| 99205 Office E&M - New | Facility | 15 | 15 | $121.29 | $1,819 |
By year: 2022 $28K for 333 services; 2023 $22K for 270 services; 2024 $27K for 494 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer M Connelly prescribed most often to Medicare patients was Levetiracetam, with 115 prescriptions and refills. In total Jennifer M Connelly wrote 652 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 115 | 282 | 37 | $4,079 |
| Dexamethasone Generic | 74 | 108 | 27 | $1,731 |
| Ondansetron Hcl Generic | 71 | 71 | 36 | $1,340 |
| Escitalopram Oxalate Generic | 32 | 56 | Under 11 | $145 |
| Mirtazapine Generic | 29 | 43 | Under 11 | $281 |
| Koselugo Selumetinib Sulfate | 24 | 24 | Under 11 | $302K |
| Lacosamide Generic | 24 | 40 | Under 11 | $5,915 |
| Lamotrigine Generic | 18 | 46 | Under 11 | $385 |
| Pantoprazole Sodium Generic | 17 | 43 | Under 11 | $114 |
| Levetiracetam Er Levetiracetam | 16 | 30 | Under 11 | $968 |
| Tibsovo Ivosidenib | 13 | 13 | Under 11 | $423K |
| Topiramate Generic | 12 | 20 | Under 11 | $232 |
Brand drugs: 73 claims; generic drugs: 579 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jennifer M Connelly $1,019 ($1,019 in general payments such as food, travel and fees) from 1 company. The largest payer was Novocure Inc. with $1,019.
| Company | Payments | Amount |
|---|---|---|
| Novocure Inc. NVCR | 8 | $1,019 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.